Home

valores Celsius abrelatas 6 diazo 5 oxo l norleucine Paso salvar Acorazado

Unbiased Metabolic Profiling Predicts Sensitivity of High MYC-Expressing  Atypical Teratoid/Rhabdoid Tumors to Glutamine Inhibition with 6-Diazo-5-Oxo -L-Norleucine. - Abstract - Europe PMC
Unbiased Metabolic Profiling Predicts Sensitivity of High MYC-Expressing Atypical Teratoid/Rhabdoid Tumors to Glutamine Inhibition with 6-Diazo-5-Oxo -L-Norleucine. - Abstract - Europe PMC

The glutamine antagonist 6-diazo-5-oxo-L-norleucine is the most... |  Download Scientific Diagram
The glutamine antagonist 6-diazo-5-oxo-L-norleucine is the most... | Download Scientific Diagram

Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant  pancreatic cancer | Scientific Reports
Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer | Scientific Reports

6-Diazo-5-oxo-L-norleucine-cancer research-TOKU-E
6-Diazo-5-oxo-L-norleucine-cancer research-TOKU-E

Chemical reactivity of 6-diazo-5-oxo-l-norleucine (DON) catalyzed by  metalloporphyrins (Fe,Ru) - ScienceDirect
Chemical reactivity of 6-diazo-5-oxo-l-norleucine (DON) catalyzed by metalloporphyrins (Fe,Ru) - ScienceDirect

Model studies towards prodrugs of the glutamine antagonist 6-diazo-5-oxo-l- norleucine (DON) containing a diazo precursor - ScienceDirect
Model studies towards prodrugs of the glutamine antagonist 6-diazo-5-oxo-l- norleucine (DON) containing a diazo precursor - ScienceDirect

157-03-9 | 6-Diazo-5-oxo-L-norleucine | = 99% (Assay by titration) -  Chem-Impex International
157-03-9 | 6-Diazo-5-oxo-L-norleucine | = 99% (Assay by titration) - Chem-Impex International

N-(Pivaloyloxy)alkoxy-carbonyl Prodrugs of the Glutamine Antagonist 6-Diazo- 5-oxo-l-norleucine (DON) as a Potential Treatment for HIV Associated  Neurocognitive Disorders | Journal of Medicinal Chemistry
N-(Pivaloyloxy)alkoxy-carbonyl Prodrugs of the Glutamine Antagonist 6-Diazo- 5-oxo-l-norleucine (DON) as a Potential Treatment for HIV Associated Neurocognitive Disorders | Journal of Medicinal Chemistry

Protective Effects of Glutamine Antagonist 6-Diazo-5-Oxo-l-Norleucine in  Mice with Alphavirus Encephalomyelitis | Journal of Virology
Protective Effects of Glutamine Antagonist 6-Diazo-5-Oxo-l-Norleucine in Mice with Alphavirus Encephalomyelitis | Journal of Virology

6 Diazo 5 Oxonorleucine - an overview | ScienceDirect Topics
6 Diazo 5 Oxonorleucine - an overview | ScienceDirect Topics

6-Diazo-5-oxo-L-norleucine - Wikipedia
6-Diazo-5-oxo-L-norleucine - Wikipedia

6-Diazo-5-oxo-L-norleucine - Wikipedia
6-Diazo-5-oxo-L-norleucine - Wikipedia

Feasibility and antitumor efficacy in vivo, of simultaneously targeting  glycolysis, glutaminolysis and fatty acid synthesis using lonidamine, 6‑ diazo‑5‑oxo‑L‑norleucine and orlistat in colon cancer
Feasibility and antitumor efficacy in vivo, of simultaneously targeting glycolysis, glutaminolysis and fatty acid synthesis using lonidamine, 6‑ diazo‑5‑oxo‑L‑norleucine and orlistat in colon cancer

Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using  Substituted Acetylated Lysine Prodrugs | Journal of Medicinal Chemistry
Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs | Journal of Medicinal Chemistry

Discovery of 6-Diazo-5-oxo-l-norleucine (DON) Prodrugs with Enhanced CSF  Delivery in Monkeys: A Potential Treatment for Glioblastoma | Journal of  Medicinal Chemistry
Discovery of 6-Diazo-5-oxo-l-norleucine (DON) Prodrugs with Enhanced CSF Delivery in Monkeys: A Potential Treatment for Glioblastoma | Journal of Medicinal Chemistry

The combination of orlistat, lonidamine and 6‑diazo‑5‑oxo‑L‑norleucine  induces a quiescent energetic phenotype and limits substrate flexibility in  colon cancer cells
The combination of orlistat, lonidamine and 6‑diazo‑5‑oxo‑L‑norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells

6-Diazo-5-oxo-L-norleucine | CAS 157-03-9 | SCBT - Santa Cruz Biotechnology
6-Diazo-5-oxo-L-norleucine | CAS 157-03-9 | SCBT - Santa Cruz Biotechnology

WO2016112386A1 - Methods for bioanalysis of 6-diazo-5-oxo-l-norleucine  (don) and other glutamine antagonists - Google Patents
WO2016112386A1 - Methods for bioanalysis of 6-diazo-5-oxo-l-norleucine (don) and other glutamine antagonists - Google Patents

6-Diazo-5-oxo-L-norleucine for Sale from Quality Suppliers - ECHEMI
6-Diazo-5-oxo-L-norleucine for Sale from Quality Suppliers - ECHEMI

6-Diazo-5-oxo-L-norleucine - Wikipedia
6-Diazo-5-oxo-L-norleucine - Wikipedia

6-Diazo-5-oxo-L-norleucine ≥98.0% (UV) | Sigma-Aldrich
6-Diazo-5-oxo-L-norleucine ≥98.0% (UV) | Sigma-Aldrich

6-Diazo-5-oxo-L-norleucine - LabNet Biotecnica
6-Diazo-5-oxo-L-norleucine - LabNet Biotecnica

6-diazo-5-oxo-L-nor-Leucine (DON, NSC 7365, CAS Number: 157-03-9) | Cayman  Chemical
6-diazo-5-oxo-L-nor-Leucine (DON, NSC 7365, CAS Number: 157-03-9) | Cayman Chemical

6-Diazo-5-oxo-L-norleucine ≥98.0% (UV) | Sigma-Aldrich
6-Diazo-5-oxo-L-norleucine ≥98.0% (UV) | Sigma-Aldrich

6-Diazo-5-oxo-L-Norleucine | VWR
6-Diazo-5-oxo-L-Norleucine | VWR

FD49029 | 157-03-9 | 6-Diazo-5-oxo-L-norleucine
FD49029 | 157-03-9 | 6-Diazo-5-oxo-L-norleucine

6-Diazo-5-oxo-L-norleucine | ≥99%(HPLC) | Selleck | Glutaminase antagonist
6-Diazo-5-oxo-L-norleucine | ≥99%(HPLC) | Selleck | Glutaminase antagonist

6-Diazo-5-oxo-L-nor-Leucine (L-6-Diazo-5-oxonorleucine) | Glutaminases  Antagonist | MedChemExpress
6-Diazo-5-oxo-L-nor-Leucine (L-6-Diazo-5-oxonorleucine) | Glutaminases Antagonist | MedChemExpress